Latest Strategic Initiatives News

Bapcor has negotiated eased lender covenants for FY27, allowing higher leverage and lower fixed charge cover ratios to support its ongoing operational reset.

Premier Investments trims FY26 Premier Retail EBIT forecast to $176 million, citing tough trading conditions and announces exit from UK Peter Alexander stores while focusing on Australian growth and loyalty programs.

Metallium Limited has demonstrated its Flash Joule Heating technology can process a broad range of critical metal feedstocks, from rare earth ores to industrial wastes, opening new commercial pathways beyond electronic waste.

Sco Technology forecasts a record FY26 with revenue up to NZ$296 million and operating EBITDA reaching NZ$36 million, reflecting strong progress on its ambitious Destination 2030 growth plan.

RPM Automotive's CEO Roy Norris resigned following mutual agreement with the board amid strategic leadership discussions. The company is launching a search for a new CEO and aims to bolster its governance with new independent directors.

Imricor Medical Systems has ignited its US commercial operations with rapid adoption by top pediatric hospitals, buoyed by FDA pediatric clearances and clinical trial progress.

Ozz Resources reported a $1.06 million loss for FY2025, deepening net liabilities and maintaining voluntary ASX suspension while advancing key exploration projects in Western Australia.

James Hardie Industries posted a 64% jump in Q1 FY27 net sales to $1.475 billion, powered by the AZEK acquisition and solid organic growth. The company exceeded EBITDA guidance and raised its full-year outlook, targeting robust sales and cash flow growth amid cautious housing market assumptions.

Integral Diagnostics has installed Jason Martinez as its new CEO, marking a leadership change as the company prepares to present its FY26 results. Martinez brings over 20 years of diagnostic imaging experience and aims to drive growth and innovation following the retirement of long-serving CEO Ian Kadish.

Globe Metals & Mining has locked in a US$600,000 unsecured working capital facility from director Bo Tan, adding short-term financial flexibility as it advances its Kanyika Niobium Project.

Stakk Ltd's combined pro forma FY2026 revenue with ParaScript has climbed to approximately A$45 million, surpassing earlier forecasts by 9%. Both companies outperformed initial revenue assumptions, setting a stronger baseline ahead of integration benefits.

Tissue Repair advances its US Phase III chronic wound trial with 100 patients randomised and targets October FDA 510(k) submission. The company reports a robust cash position bolstered by R&D refunds and has cut manufacturing scale-up costs.